InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Drugs company questions patent pool concept

Emma Barraclough, Brussels


A lawyer for one of the world’s biggest pharmaceutical companies has said that pooling patents over drugs will not solve the major problems of access to medicines

Speaking at the Competition 2009 conference in Brussels on Friday, Stéphane Drouin, head of European patents at Pfizer, said that IP is not a major issue when it comes to accessing drugs in least developed countries.


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements